Germline alterations in BRCA1 drive about 40%–45% of familial breast cancers but represent only 2%-3% of all breast cancer cases, since BRCA1 mutations are uncommon in sporadic tumors [18]. This evidence concerns the gene BRCA1 and breast carcinoma.